Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) EBT (2016 - 2025)

Historic EBT for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $255000.0.

  • Champions Oncology's EBT fell 6549.39% to $255000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.4 million, marking a year-over-year increase of 47059.75%. This contributed to the annual value of $4.6 million for FY2025, which is 16330.05% up from last year.
  • Champions Oncology's EBT amounted to $255000.0 in Q4 2025, which was down 6549.39% from -$452000.0 recorded in Q3 2025.
  • Champions Oncology's 5-year EBT high stood at $4.5 million for Q1 2025, and its period low was -$2.5 million during Q2 2023.
  • Over the past 5 years, Champions Oncology's median EBT value was -$246000.0 (recorded in 2022), while the average stood at -$361400.0.
  • As far as peak fluctuations go, Champions Oncology's EBT surged by 170625.0% in 2021, and later plummeted by 10290000.0% in 2023.
  • Quarter analysis of 5 years shows Champions Oncology's EBT stood at $289000.0 in 2021, then tumbled by 100.69% to -$2000.0 in 2022, then tumbled by 102900.0% to -$2.1 million in 2023, then skyrocketed by 135.87% to $739000.0 in 2024, then tumbled by 65.49% to $255000.0 in 2025.
  • Its EBT was $255000.0 in Q4 2025, compared to -$452000.0 in Q3 2025 and -$2.0 million in Q2 2025.